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Abstract
Domestic dogs can suffer from hearing losses that can have profound impacts on working ability and quality of life. We have
identified a type of adult-onset hearing loss in Border Collies that appears to have a genetic cause, with an earlier age of
onset (3–5 years) than typically expected for aging dogs (8–10 years). Studying this complex trait within pure breeds of dog
may greatly increase our ability to identify genomic regions associated with risk of hearing impairment in dogs and in
humans. We performed a genome-wide association study (GWAS) to detect loci underlying adult-onset deafness in a sample
of 20 affected and 28 control Border Collies. We identified a region on canine chromosome 6 that demonstrates extended
support for association surrounding SNP Chr6.25819273 (p-value = 1.09610213). To further localize disease-associated
variants, targeted next-generation sequencing (NGS) of one affected and two unaffected dogs was performed. Through
additional validation based on targeted genotyping of additional cases (n = 23 total) and controls (n = 101 total) and an
independent replication cohort of 16 cases and 265 controls, we identified variants in USP31 that were strongly associated
with adult-onset deafness in Border Collies, suggesting the involvement of the NF-kB pathway. We found additional support
for involvement of RBBP6, which is critical for cochlear development. These findings highlight the utility of GWAS–guided
fine-mapping of genetic loci using targeted NGS to study hereditary disorders of the domestic dog that may be analogous
to human disorders.
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Introduction
Age-related hearing loss (presbycusis) occurs in humans with a
prevalence of about 40% in individuals older than 65 years of
age. It is associated with difficulties of communication, isolation,
depression and possibly even dementia in the severely affected
[1]. There are extensive genetic contributions to hearing
variation [2], which has an estimated heritability of 35–55%
(reviewed in [3]). Studies in humans have identified risk-
conferring variants in both mitochondrial [4,5] and autosomal
DNA (reviewed in [3]). A recent genome-wide association study
(GWAS) performed in an isolated Finnish population identified
the candidate gene IQ motif containing GTPase activating protein 2
(IQGAP2) as a novel risk locus for hearing loss [6], as well as
modest support for another, previously identified GWAS
candidate, metabotropic glutamate receptor 7 (GRM7) [7]. Overall,
however, the breadth of genetic variation that may confer risk for
this common disorder remains unknown.
The domestic dog offers a unique opportunity to explore the
genetic backgrounds of naturally occurring disorders that are
analogous to human diseases. Genomic studies are particularly
informative when a disorder of interest demonstrates a simpler
inheritance pattern in dogs than in humans, suggesting one or a
few main risk alleles. Deterioration of hearing with age is normal
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in dogs, with an onset at 8–10 years [8] that corresponds with
physiological changes in critical systems in the ear, including
reduced spiral ganglion neuronal density in the cochlea [9].
Shimada et al. [10] reported that dogs with hearing loss
demonstrated the same four types of lesions found in humans
(as described by Schuknecht & Gacek [11]): sensory, neural,
strial and cochlear conductive lesions. Physiological measure-
ments of hearing ability using brainstem auditory evoked
response (BAER) demonstrate similar patterns in dogs and
humans, with high- and mid-range frequencies being the most
severely affected [8,12]. Thus, age-related hearing loss may be
similar in both clinical presentation and underlying pathology in
humans and dogs.
Across breeds, presbycusis is estimated to begin at 8–10 years,
when deterioration is observed at all frequencies [8]. However,
adult-onset deafness in Border Collies often has an earlier onset
(3–5 years) than deafness resulting from the physiological aging of
hearing organs. Distinct from other breeds, the Border Collie has
been selected for over 100 years to perceive and respond to
whistle commands while working at distances of 800 meters or
more from a handler. Being able to detect slight differences in
whistle tones is essential to the function of a working Border
Collie, and even moderate hearing loss in one ear can have a
major impact on working ability. Although relatively uncommon
in Border Collies, adult-onset deafness is considered especially
problematic because hearing is so integral to the tasks for which
these dogs are selectively bred and used. In addition, dogs
afflicted by adult-onset deafness are often in their prime working
years, with the average age of top working dogs around 7 years
[13].
The earlier age of onset in affected Border Collies suggests that
adult-onset deafness is genetically influenced and possibly more
severe than that observed in other breeds of dogs. Many of the
affected dogs included in this study were reported by their owners
to have one or more first-degree family members with similar
deafness. We undertook a study to identify genetic risk factors and
address concerns regarding adult-onset deafness among Border
Collies, as well as potentially gain information about analogous
human conditions.
Results
Adult-Onset Deafness in Border Collies
The exact age of onset of hearing deterioration is often difficult
to ascertain in pet dogs, because subtle changes may go unnoticed
by pet owners and because dogs are known to compensate for
hearing loss [14]. However, the owners of the dogs included in this
study estimated the age of onset of hearing loss based upon close
observations of behavioral characteristics in working dogs indicat-
ing poor hearing (e.g., reduced call distance, poor performance).
The average estimated age of onset was 4.3 years (S.E. of 0.5
years), with a range of 1–9 years.
Genome-Wide Association Study
A total of 48 unrelated Border Collies (20 cases, 28 controls)
were utilized for the primary association study (Table S1).
Following quality control of the genotype data, 30,231 SNPs were
retained for genetic mapping. Genome-wide association analyses
with EMMAX identified a region on CFA6, at approximately
25 Mb (Figure 1). In total, 25 markers exhibited significance
beyond a Bonferroni-corrected threshold (p= 1.6561026 for
30,231 tests). The strongest finding was an intergenic SNP,
Chr6.25819273, with a p-value of 1.09610213 (Table 1), with
strong regional support demonstrated by neighboring SNPs
whereby, within 1 Mb flanking the top finding, six reached
Bonferroni significance. The closest predicted gene to this SNP is
HS3ST2, approximately 24 kb downstream of the marker.
HS3ST2 is a member of the heparan sulfate biosynthetic enzyme
family, and is expressed predominantly in the brain [15].
Associations were also assessed through permutation analysis in
PLINK. One million permutations yielded genome-wide permu-
tated p-values that achieved genome-wide significance (Table 1).
Analyses of copy number variation using genome-wide SNP data
did not reveal evidence of structural changes associated with
hearing loss. Association modeling suggested an autosomal
recessive mode of inheritance for adult-onset deafness in Border
Collies.
Fine-Mapping
The large candidate region identified on CFA 6 was syntenic
with human 16p12.1-p12.3, which encompasses the human
autosomal recessive deafness locus DFNB22 [16]. A candidate of
immediate interest within this region was the gene OTOA, defects
of which were implicated in a case of prelingual sensorineural
deafness in a consanguineous Palestinian family [16]. We
performed PCR amplifications of the 28 exons and a highly
conserved non-coding region. PCR products were sequenced and
analyzed for mutations in affected dogs. None of the observed
polymorphisms tracked specifically in affected dogs.
Given the large region of association and lack of polymorphisms
in the strong candidate gene OTOA, we next narrowed the critical
region for the 25-Mb locus by haplotype analysis. We detected a 7-
SNP haplotype that was homozygous in all cases but only once
among the control samples (see Discussion). A larger 11-SNP
haplotype was found homozygous in 19 of 20 cases and present in
the same control. (Figure 2). For sequencing via target capture and
next-generation sequencing (NGS), we selected an affected dog
that was homozygous for the extended 11-SNP risk haplotype at
25 Mb (Figure 2). Two control dogs that did not carry the
candidate risk haplotype were also sequenced after target capture
by NGS.
The risk haplotype spanning the coordinates on CFA6 from
25.5–25.9 Mb was used to guide mutation discovery with the NGS
data. We identified predicted genes based on synteny and the
Author Summary
The domestic dog offers a unique opportunity to study
complex disorders similar to those seen in humans, but
within the context of the much simpler genetic back-
grounds of pure breeds, which represent closed popula-
tions. We performed a whole-genome search for genetic
risk factors of adult-onset deafness in the Border Collie, a
breed of herding dog that relies on acute hearing to
perceive and respond to commands while working. Adult-
onset deafness in Border Collies typically begins in early
adulthood and is similar to age-related hearing loss in
humans. This earlier onset has particular impact on the
utility of working Border Collies and the livelihoods of their
owners, and it appears to have a genetic cause. We
identified three genetic variants that were strongly
associated with adult-onset deafness in a sample of 405
Border Collies. These variants are located in two genes that
have previously been linked to deafness, one involved in
ear development and another that appears to mitigate
tissue damage in the ear. These results provide new insight
regarding genetic risk factors for age-related hearing loss
in both dogs and humans.
GWAS of Adult-Onset Deafness in Border Collies
PLOS Genetics | www.plosgenetics.org 2 September 2012 | Volume 8 | Issue 9 | e1002898
annotated gene index, and designed a solution-based target
capture mixture to target exons and introns, along with at least
1 kb of upstream and downstream regions possibly inclusive of
UTR sequence. This capture design encompassed 2.3 Mb, and
included 73 genes. NGS rendered over 30 million reads per
sample (Table S2). More than 90% of these reads could be aligned
to the reference genome sequence (CanFam2). Of the total
targeted sequence, 75% had greater than 106 coverage, and
nearly 70% had .306 coverage (Table S7).
The numbers and types of variants identified are summarized in
Table S3. One strong non-synonymous SNP (nsSNP) candidate,
Chr6.25714052, is located in exon 17 of USP31, which encodes an
ubiquitin specific peptidase. It is an A.G variant that is predicted
to cause an I847V change in the resulting protein product. The
position is highly conserved, with a phastCons score of 0.95 (Table
S4), although SIFT predicted the change to be tolerated (SIFT
score of 0.66). Also of note in USP31 is an intronic T.G SNP
(Chr6.25681850) that is very highly conserved (phastCons score of
0.98) and is 5 bp away from an intron-exon boundary. This
variant was called G/G in the case and T/T in both controls. Both
variants are located within the risk haplotype.
Another candidate nsSNP, Chr6.24500625, is in exon 18 of
RBBP6, encoding a retinoblastoma binding protein. This nsSNP
changes threonine to asparagine at residue 1,397. This G.T
variant was called T/T in the case and G/G in both controls.
SIFT predicted the change to be tolerated (SIFT score = 0.69;
Table S4). Although the conservation score for this SNP is low
(phastCons = 0.001) and the variant is located upstream of the
main risk haplotype, RBBP6 (also known as PACT) plays a critical
role in ear development and hearing; disruption of the gene has
been shown to cause congenital hearing impairment in mice [17]
and suggests high relevance to hearing loss in dogs. The
sequencing data from 25 Mb did not exhibit variants in OTOA
that were homozygous in the case but not in controls. Therefore,
we did not consider this to be the causative gene. Although small
insertion/deletion variants were found in the mapped intervals,
none of these variants appeared to be causal.
The three variants described above, Chr6.24500625 in RBBP6,
and Chr6.25681850 and Chr6.25714052 in USP31, were the most
compelling for follow-up genotyping analyses due to biological
implications (RBBP6) and location within the risk haplotype
(USP31), and were analyzed both for validation (primary mapping
cohort) and replication (independent cases and controls).
Validation
Genotyping was performed via dye-terminator sequencing for
the three chosen variants. All three showed associations with adult-
onset deafness (Table 2). For replication analysis, we genotyped an
independent Border Collie cohort of 16 cases and 265 controls. All
three SNPs were strongly associated with adult-onset deafness
(Table 2), replicating our previous mapping results. Meta-analysis
of the combined primary and replication cohorts yielded even
Figure 1. Manhattan plot of GWAS for adult-onset deafness. Chromosome markers are plotted on the x-axis in order and alternately shaded.
The -log10(p-value) is plotted on the y-axis. The red line indicates significance at the Bonferroni-corrected level for 30,000 SNPs. There is extensive
regional support for an association on CFA6. The inset shows an enlargement of the 25-Mb association region, including genes of interest. The raw
GWAS and permuted p-values (Pperm-gw) for the top SNP are also given.
doi:10.1371/journal.pgen.1002898.g001
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stronger associations for all three variants. The strongest
association was found for the variant of USP31, Chr6.25681850,
with p= 6.16610222 (Table 2).
Discussion
Our results represent the first GWAS of adult-onset deafness in
the domestic dog. We demonstrated the successful application of
target capture for next-generation sequencing (NGS) in the dog.
The region implicated by GWAS in our study is syntenic to
regions implicated in congenital sensorineural deafness in humans.
In this study, we identified three strong candidate coding and
non-coding variants associated with adult-onset deafness. The
strongest is Chr6.25681850, an intronic SNP in USP31 that is 5 bp
from an intron-exon boundary and may play a role in alternate
splicing (as annotated in humans). Preliminary studies of mRNA
collected from peripheral blood samples from two dogs harboring
this variant did not suggest changes in RNA splicing in this region,
though tissue-specific changes in RNA regulation cannot be ruled
out. USP31 is a ubiquitin-related gene that has been linked to
Parkinson’s disease in humans [18]. The implication of a
ubiquitin-related gene in adult-onset deafness is particularly
intriguing given the histological findings of Shimada et al. [10],
which included ubiquitin-positive granules in the neuropil of
cochlear nuclei of aging dogs. USP31 has also been shown to
regulate NF-kB activation; NF-kB deficiency is associated with
increased levels of cochlear apoptosis and hearing loss [19,20].
Despite its location outside the main risk haplotype implicated in
the primary GWAS, the second-strongest association was the
nsSNP Chr6.24500625, which is exonic to RBBP6, a gene
previously implicated in hearing in a knockout mouse model
[17]. In addition to roles in development, RBBP6 may also be
involved in chaperone-mediated ubiquitination and protein
quality control [21], suggesting another potential role in pathol-
ogy. A second USP31 SNP, Chr6.25714052, was also associated
with adult-onset deafness in our cohort, although this locus had the
lowest odds ratio of the three candidate loci.
There are several caveats to the present study. A recent human
GWAS for presbycusis adjusted phenotypes for hearing thresholds
according to age and sex, due to observed variability in hearing
threshold in males and females [6]. We elected not to correct for
sex in our canine study because such sexual dimorphism is not yet
established in aging dogs [8,10,12,14]. Further, we did not adjust
for age because the age of onset for our sample cohort, which is
likely a specific trait of this form of hearing loss, was owner-
estimated. The mean age of our control group was 6.6 years,
Table 1. Top 25 ranked findings from analysis for presbycusis in Border Collies.a
SNP A1/A2 FreqCase FreqControl PEMMAX PAllelic PPerm OR (95% CI)
Chr6.25819273 C/A 0.00 0.78 1.09E-13 6.42E-14 1.00E-06 N/A
Chr6.26517587 A/G 0.83 0.14 1.64E-10 2.71E-11 1.00E-06 28.29 (9.35–85.57)
Chr6.24591869 T/C 0.10 0.77 4.46E-10 1.09E-10 2.00E-06 0.034 (0.01–0.11)
Chr6.24577002 C/T 0.89 0.20 5.68E-10 2.91E-11 1.00E-06 34.77 (10.18–118.7)
Chr6.25174415 C/G 0.10 0.78 1.07E-09 8.06E-11 2.00E-06 0.03 (0.01–0.11)
Chr6.28753894 A/G 0.78 0.13 1.78E-09 1.36E-10 3.00E-06 24.11 (8.15–71.38)
Chr6.25181733 G/A 0.89 0.21 2.03E-09 9.38E-11 2.00E-06 31.17 (9.23–105.20)
Chr6.22844453 G/A 0.80 0.19 5.21E-09 3.07E-09 2.60E-05 17.6 (6.25–49.56)
Chr6.29363433 T/G 0.78 0.15 9.45E-09 1.07E-09 6.00E-06 19.81 (6.89–56.92)
Chr6.24570819 T/G 0.10 0.75 1.07E-08 3.28E-10 4.00E-06 0.037 (0.01–0.12)
Chr6.21475826 C/T 0.80 0.23 1.83E-08 3.87E-08 4.20E-04 13.23 (4.90–35.7)
Chr8.62484232 T/G 0.00 0.37 3.75E-08 1.44E-05 1.70E-01 N/A
Chr6.25913101 C/T 0.00 0.61 4.14E-08 8.67E-10 5.00E-06 N/A
Chr6.29470484 T/C 0.76 0.15 5.20E-08 3.15E-09 2.60E-05 18.53 (6.42–53.46)
Chr6.35491820 G/C 0.50 0.04 1.00E-07 2.68E-07 2.82E-03 25.00 (5.34–117.00)
Chr6.23160353 C/A 0.53 0.05 1.95E-07 1.45E-07 1.57E-03 19.53 (5.23–72.98)
Chr6.23166082 G/A 0.53 0.05 1.95E-07 1.45E-07 1.57E-03 19.53 (5.23–72.98)
Chr6.25900591 G/A 0.00 0.54 2.21E-07 2.37E-08 2.21E-04 N/A
Chr6.26959216 C/A 0.03 0.61 2.40E-07 5.15E-09 3.60E-05 0.02 (0.002–0.13)
Chr6.34915222 G/A 0.63 0.14 3.21E-07 9.41E-07 1.18E-02 10.00 (3.74–26.77)
Chr6.23177930 C/T 0.53 0.06 3.48E-07 2.46E-07 2.57E-03 18.79 (5.02–70.3)
Chr6.26917473 C/A 0.03 0.59 3.67E-07 1.20E-08 9.50E-05 0.02 (0.002–0.14)
Chr6.24104844 A/G 0.08 0.66 3.76E-07 9.54E-09 7.30E-05 0.04 (0.01–0.15)
Chr6.34819558 A/T 0.03 0.38 8.32E-07 5.76E-05 5.31E-01 0.04 (0.005–0.33)
Chr6.22861769 T/A 0.50 0.05 1.58E-06 4.37E-07 4.99E-03 17.67 (4.73–66)
aSNP: marker name (location information); A1: risk allele; A2: reference allele; FreqCase: allele frequency of A1 in cases; FreqControl: allele frequency of A1 in controls;
PEMMAX: p-values from EMMAX primary GWAS; PAllelic: p-values from allelic association analysis; PPerm: genome-wide (EMP2) permuted p-values from PLINK; OR (95% CI):
odds ratio with 95% confidence interval as calculated with logistic regression.
All top 25 hits from the EMMAX analysis reached statistical significance at the Bonferroni-corrected level, and all but one are on CFA6. All top 25 findings also reached
genome-wide significance after empirical significance testing with permutation. Odds ratios calculated in PLINK demonstrate strong effects for all top hits.
doi:10.1371/journal.pgen.1002898.t001
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which is close to the range of hearing loss onset. Therefore, it is
possible that dogs categorized as ‘‘controls’’ may, at later stages in
life, demonstrate hearing loss similar to that observed in cases. For
example, one interesting case involves a dog that was classified as a
control at the time of collection (41 months old) and was shown to
carry the 11-SNP risk haplotype we identified in affected dogs (this
dog is indicated by the asterisk in Figure 2). This dog was later
found to have several deaf siblings. In the follow-up SNP
genotyping cohort, several Finnish dogs classified as controls by
owner questionnaires were also found to carry one or more of the
risk alleles identified during NGS (Table 2). Two of these dogs
were later found to have had changes in hearing since initial
sample collection, and further inquiry uncovered additional family
histories of hearing loss in both dogs’ pedigrees. However, the
misclassification of cases as controls would only reduce analytical
power to detect genetic associations, and would not result in
spurious associations. Given the strengths of the associations we
identified on CFA6, this does not seem to be a concern. Similarly,
the presence of the risk haplotype in the homozygous state in all
cases suggests that we are not detecting phenotypic heterogeneity
influenced by another locus, such as occult congenital unilateral
pigmentation-related forms of deafness.
Another caveat stems from the fact that we performed target
enrichment for selected regions (i.e., all predicted genes) of
extended association loci, and therefore non-coding variants far
outside of known or predicted genes were potentially missed.
Target enrichment results in uneven coverage, so variants may be
missed because not all positions are covered equally well, although
the regions that were captured appear to be well assembled
(Figures S3, S4; Table S6). Finally, the magnitude of our findings
on CFA6 in the primary GWAS (Figure S2) likely overshadowed
signals from other regions, even if modifying loci were present.
A strength of canine research highlighted by this study is the
reliability of owners to assess phenotype. Each case in the GWAS
for adult onset hearing loss was scored by the owner. The results of
mapping showed that every case was homozygous for an ancestral
risk haplotype, providing compelling support of the initial owner
assessment. We view this as tapping the same insights gained by a
parent, who develops an intimate awareness of their child’s health
and behavior. Our results have implications for researchers
interested in other canine behavioral traits, in that owner-based
observation may be sufficient, at least initially, to advance genetic
studies.
Although we observed robust associations and replications,
none of the candidate SNPs we identified tracked perfectly with
adult-onset deafness. This discrepancy has several possible
explanations: 1) adult-onset deafness in the Border Collie is a
multigenic trait, 2) the risk locus shows incomplete penetrance, or
3) the variants we identified are in linkage disequilibrium with the
true disease-causing mutation. The fact that the RBBP6 SNP
demonstrated a stronger association than the second USP31 SNP,
Chr6.25714052, likely reflects extended linkage in cases that was
not readily apparent in haplotype analyses, and may provide
information regarding the location of the true causative variant.
Given that the 7-SNP homozygous haplotype is present in all
cases, it is likely that the variants we identified, which do not track
Figure 2. Haplotypes in CFA6 region 25 Mb. Each box color
represents a different genotype, as indicated by the key; dogs are listed
in rows and SNPs in columns. Case dogs are all homozygous for a single
haplotype spanning 7 markers, and all but one case also share an 11-
SNP haplotype (for which the single dog is heterozygous). One sample
used as a control (marked with *) also carries the 11-SNP risk haplotype.
doi:10.1371/journal.pgen.1002898.g002
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perfectly with larger samples of cases, are more recent in origin
than the common tagging SNPs utilized in array genotyping. This
would suggest that the causative variant has occurred within the
context of a broader, ancestral haplotype. The causative mutation
for adult-onset deafness may be a non-coding variant between
Chr6.24500625 and Chr6.25681850 that was not captured during
target enrichment, and structural variation may also be missed
with this technology. Numerous mapping studies in the dog have
identified structural variants as causative mutations of traits or
disorders [22].
The risk allele of the most strongly-associated SNP from NGS
exhibited a frequency of 0.23–0.31 in our Border Collie control
sample (Table 2). Future studies may clarify whether this risk allele
occurs at similar frequencies in other breeds of dog. Alternative
mapping strategies utilizing highly polymorphic microsatellite
markers in haplotypes and including different breeds of dog may
allow for more refined mapping of structural variants underlying
adult-onset deafness. In light of our strong genetic findings,
longitudinal studies of dogs that carry risk alleles are warranted for
further phenotypic characterization, including histopathologic
examination of the middle ears and cochlea. Such investigations
may allow us to further characterize and explore the hypothesis
that these animals are affected by pure sensorineural deafness, as
demonstrated by BAER testing. Observations of the effects of risk
variants on aspects of hearing throughout the aging process could
provide critical prognostic information for the development of
diagnostic or therapeutic tools for use in clinical contexts in both
dogs and in humans. It is possible that hearing loss is identified
earlier by handlers of dogs for which working ability depends
strongly on hearing acuity, such as working Border Collies.
Physiological findings may thus be particularly relevant to studies
of other utility-bred dogs, in addition to studies of hearing loss that
naturally occurs in geriatric dogs.
In conclusion, we identified candidate variants on CFA6 that
are strongly associated with adult-onset deafness in Border Collies,
with promising implications for future pre-morbid identification of
at-risk dogs or applications to human studies. Preliminary
causative variant fine-mapping analyses indicate that variants in
USP31 and RBBP6 may be involved in disease etiology. Future
studies to elucidate the roles of these variants in canine adult-onset
hearing loss will include haplotype mapping for the detection of
structural variations and longitudinal studies of gene effects on
hearing electrophysiology trajectories and outcomes.
Materials and Methods
Ethics Statement
All work related to animals was performed with the approval of
the Institutional Animal Care and Use Program at the University
of California, San Francisco (AN079848-02). Collection of blood
samples in Finland was approved by the Animal Ethics Committee
at the State Provincial Office of Southern Finland (ESLH-2009-
07827/Ym-23). The canine samples used were provided by
private dog owners, who consented to the use of de-identified data
for research purposes.
Samples
Whole blood samples (3–8 mL) from a total of 48 purebred
Border Collies collected in the United States (U.S.) were used for
primary GWAS. Samples from 20 affected working Border Collies
recruited from owners from the sheepdog/herding community
were collected specifically for this genetic survey of risk loci for
adult-onset deafness. Twenty-eight control samples (unrelated at
the grandparental level, per pedigree analysis) were collected at
sheepdog trials or sent directly to the laboratory by owners and
breeders in the context of ongoing genetic studies of canine
behavior and complex disease. The 20 adult-onset deafness cases
included 9 males and 11 females, and the 28 controls included 15
males and 13 females (mean age of controls, 6.6 years). One of the
cases and two controls were also sequenced using next-generation
sequencing (NGS) technology. An additional 14 U.S. controls and
3 cases and 59 controls collected in Finland were used for follow-
up genotyping of candidate variants. Finally, samples from 16
cases and 265 controls were also collected in the U.S. to serve as
an independent replication cohort. All follow-up and replication
samples were from purebred Border Collies. Although consisting
primarily of distinct breeding lines, the Finnish dogs demonstrated
similar allele frequencies for the genotyped variants as the U.S.
dogs, and thus both groups were analyzed together. The use of a
covariate to account for difference in country of origin/breeding
line did not change the results of association analysis. DNA was
extracted using standard protocols. A summary of the samples is
provided in Table S1.
Phenotypes
Adult-onset deafness phenotypes were assigned based on owner
responses to verbal questions to determine whether or not a
Table 2. Summary of association results with combined data from all stages of study.a
Primary Replication
SNP Gene A1/A2 FrCase/FrCont P OR FrCase/FrCont P OR Comb. P
n=23/n=101 n=16/n =265
Chr6.24500625 RBBP6 T/G 0.91/0.38 1.98E–10 16.32 0.69/0.41 0.0019 3.20 1.01E–9
(5.62–47.41) (1.49–6.89)
Chr6.25681850 USP31 G/T 0.98/0.31 3.24E–16 97.98 0.72/0.23 8.57E–10 8.55 6.16E–22
(13.19–727.90) (3.85–18.96)
Chr6.25714052 USP31 G/A 0.98/0.74 0.0012 13.52 0.91/0.71 0.016 3.96 0.00015
(1.81–100.90) (1.19–13.19)
aSNP: marker name (location information); A1: risk allele; A2: reference allele; FrCase: allele frequency of A1 in cases; FrCont: allele frequency of A1 in controls; P: p-values
from allelic association analysis; OR: odds ratio with 95% confidence interval; Comb. P: combined p-value from meta-analysis.
The strength of association of the three variants is shown. Chr6.24500625 in RBBP6 and Chr6.25681850 in USP31 remain highly significant after inclusion of more cases
and controls.
doi:10.1371/journal.pgen.1002898.t002
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sampled dog exhibited hearing loss that had developed in
adulthood (i.e., deafness that was not congenital). Hearing loss
was determined indirectly by owner observations of working dogs
that were previously responsive to verbal and whistle commands
given in both home and working conditions, but as adults
demonstrated significant decreases in response or apparent
inability to hear commands. Such loss of hearing was often
observed to take place over the course of several months or years.
Some owners said that they did not notice any significant changes
in their dogs’ hearing ability until much later in the dogs’ lives, but
they suspected that the dog was ‘‘compensating’’ in the work
environment by observing the handlers’ physical cues or by
moving closer to the handler when commands were being given.
Controls for the primary GWAS portion of the study were herding
Border Collies that met two criteria: 1) genetic clustering in the
same group as affected dogs (genetic matching), and 2) no hearing
loss indicated in the health sections of behavioral questionnaires
completed by owners at the time of sample collection. For follow-
up and replication genotyping, U.S. cases were identified as above
and controls were defined as dogs that displayed no hearing loss as
indicated by owners at the time of sample collection. For all
Finnish dogs, deafness phenotypes were obtained through owner
interviews via questionnaires.
Genome-Wide Genotyping
SNP genotyping was performed on the Affymetrix Custom
Canine Array v2.0 according to the manufacturer’s protocol, a
perfect-match-only array targeting 127,000 SNPs (Affymetrix,
Santa Clara, CA, USA). Genotypes were called using the
BRLMM-P algorithm in Affymetrix Power Tools (apt-1.12.0).
Genotype quality control (QC) was first implemented for all of the
samples we genotyped on the Affymetrix array for ongoing studies
of complex disease (n = 275), which included unrelated dogs as
well as a subset of related dogs to assess Mendelian errors. SNP
exclusion criteria for the full set were call rates by marker and by
individual,95%; concordance of replicate control sample geno-
types across all genotyping runs,100%; X-chromosome markers;
deviations from Hardy-Weinberg equilibrium with p-val-
ues,0.001; minor allele frequency,0.02; and Mendelian er-
rors.5% per SNP. This filtering resulted in a primary dataset of
about 40,000 SNPs. After additional QC on only the 48 unrelated
samples included in the GWAS for adult-onset deafness (exclu-
sions: SNP call rate,95%, MAF,0.05), approximately 30,000
SNPs were retained for final analysis. QC was performed using
Stata10/MP (StataCorp LP, College Station, TX, USA) and
PLINK (v1.06–1.07 [23]).
Target Capture and Next-Generation Sequencing
Genomic library sample preparation was performed using the
Illumina single-end library sample preparation kit (Illumina Inc.,
San Diego, CA, USA). Sample preparation was carried out
according to the manufacturer’s instructions, except for slight
modifications as follows: 3 mg of genomic DNA were sheared via
sonication (S-4000 with 2.50 diameter cup horn, Misonix, Inc.,
Farmingdale, NY, USA); all purification steps were performed
using Agencourt AMPure XP magnetic beads (Beckman Coulter,
Inc., Brea, CA, USA); seven cycles of ligation-mediated PCR were
used for library amplification. Sample libraries were run on a
Bioanalyzer 2100 for DNA quantitation and confirmation of
fragment size distribution (High Sensitivity DNA Kit, Agilent
Technologies, Waldbronn, Germany). For targeted sequencing,
we performed solution-based capture with the Agilent SureSelect
Target Enrichment System Kit. Briefly, a custom panel of 120-
base cRNA oligos was designed to target 1000 bp upstream and
downstream of 73 predicted gene sequences based on mammalian
alignments (or in one case, frog) to CanFam2 in the candidate
region on CFA6 (Table S6). The target regions were covered by
approximately 43,000 probes that were designed for 36 coverage
(i.e., each base was covered by three different probes). The
prepared genomic libraries were hybridized to the panel of biotin-
labeled ‘‘bait’’ oligos for 24 hours. Targets were pulled down via
streptavidin magnetic beads, purified, and enriched through 13
cycles of PCR amplification. Samples were single-end sequenced
on an Illumina Genome Analyzer IIx for 76 cycles.
Dye-Terminator Sequencing
Three variants were selected for genotyping via dye-terminator
sequencing. All samples included in the study were sequenced. A
PCR amplicon was designed for each region, and sequencing was
performed in the forward and reverse directions (primer sequences
provided in Table S5). We used 1 mL of 1 ng/mL of DNA as input
for each standard PCR reaction. Platinum-Taq polymerase was
used to amplify segments with a 58uC touchdown protocol in the
presence of 0.4 mM primer, 100 mM dNTPs, 2.5 mM Mg and
1 mM betaine.
Data Analysis
GWAS. Primary GWAS analysis was performed using the
beta version of Efficient Mixed-Model Association eXpedited
(EMMAX) [24]. We used a mixed model-based analysis to
account for population stratification or cryptic relatedness that
may have been present in the sample (as pedigrees were not
available for cases). In addition, allelic associations with one
million permutations were performed in PLINK (v1.07, [23]) to
further assess association strength and rule out false positives.
Permutation analysis consists of reassigning case-control labels
randomly (in this case, through one million iterations) and then
identifying the distribution of resultant associations at each SNP
for all random case-control assignments. This normal distribution
of possible associations is then compared to the actual phenotype
association; the genome-wide permuted p-value represents the
probability of seeing a spurious (random) association from the
permutation-obtained normal distribution that is stronger than the
observed association. For one million permutations, p = 161026
states that no random association was stronger than the true
finding. In the PLINK analysis, we did not correct for within-
breed stratification by the incorporation of principal components
or multi-dimensional scaling vectors, since the analyzed dogs had
been genetically matched (Figure S1). Finally, haplotype analysis
was performed in PLINK, with results visualized using the web-
based Genome Variation Server (GVS) (http://gvs.gs.washington.
edu/GVS/index.jsp) and Haploview.
NGS. Bowtie [25] was used for read alignment against
CanFam2, allowing up to 2 mismatches in the first 60 bases of a
given read. SAMtools [26], Picard (http://picard.sourceforge.net/
), BEDTools [27], and the Genome Analysis Toolkit (GATK, [28])
were used for post-alignment processing. Multi-sample realign-
ment around potential insertion/deletions (indels) and base quality
score recalibration were both performed prior to variant calling by
GATK’s Unified Genotyper. Indels were called using Dindel [29].
ANNOVAR [30] was used to annotate and prioritize variants.
Phastcons4way scores, which provide a measure of conservation
based on multi-species alignment, were obtained from the UCSC
Genome Browser [31].
Dye-terminator sequencing. Genotype calls for the three
variants were made manually by inspection of sequence traces.
Association testing was performed in PLINK, and false positives
were assessed by subsequent permutation testing. Allele frequencies
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of variants between the Border Collies from the U.S. and Finland
were not significantly different, according to Fisher’s exact test for
homogeneity; further, all associations remained when ancestry was
added as a covariate (data not shown). The two groups were thus
treated as a single group in follow-up analysis.
Meta-analysis of candidate variants. A sample size
weighted analysis based on p-values generated in the primary
and replication cohorts was performed using METAL [32].
Supporting Information
Figure S1 Multi-dimensional scaling (MDS) vector plots of
Border Collies used for deafness analysis. MDS1 x MDS2 based
on data from all unrelated Border Collies genotyped by our group
for ongoing studies of behavior. A total of 10 MDS covariates were
calculated for all Border Collies using a subset of unlinked (r2,0.8)
whole genome SNP data (,22 k markers total) in PLINK.
Matched controls (blue) were selected based on genetic similarity
to cases (red) for the primary GWAS. Samples in gray are shown
to demonstrate the overall genetic diversity found in our entire
Border Collie cohort.
(PDF)
Figure S2 Q-Q plot of GWAS analysis for adult-onset deafness
in Border Collies. Expected versus observed –log10(p-value) for the
primary GWAS are plotted for each marker; the red line indicates
the null distribution. Given the strong association signal by
multiple linked markers on CFA6, findings with p-values less than
0.0001 were removed from this plot to avoid skewing the graphical
distribution at high observed p-values. The Q-Q plot for this
analysis suggests that there is minimal population stratification in
this sample, as the majority of points lie on the null distribution.
(PDF)
Figure S3 Number of gaps in the canFam2 assembly from
23 Mb to 29 Mb by size. There were 80 gaps in the canFam2
assembly ranging from 1 bp to 2707 bp (mean=388 bp; med-
ian= 217 bp). The gaps sum to 31089 bp, or about 0.5% of the
sequence within the region.
(PDF)
Figure S4 Sequencing assembly quality scores of target capture
region in the canFam2 assembly. As shown, most (98%) of the
bases in the assembly have quality scores equal or bigger than 40
(deemed high confidence).
(PDF)
Table S1 Sample summary. Samples for the primary genome-
wide association study (GWAS) and targeted genotyping were
collected from two countries, with breakdown of cases and controls
provided for a total of 405 Border Collies.
(DOCX)
Table S2 Next-generation sequencing statistics. Each sample
was run in a single lane for 76 sequencing cycles. Given the high
number of variants called, we first filtered variants with regard to
their genotype in cases and controls, filtering for variants called
homozygous in the case sample and called not homozygous for
that variant in either of the controls. We then focused on exonic
and potentially functional non-coding variants, with priority given
to top biological candidates. For a summary of SNPs as annotated
in ANNOVAR, see Table S4.
(DOCX)
Table S3 Summary of variants homozygous in case and not in
controls using ANNOVAR. Number of SNPs of different locations
and functional relevance as annotated by ANNOVAR are
provided for total experiment and for which the variants are
homozygous in the case sample but not in either control sample
(assuming a recessive mode of inheritance as suggested by
homozygous risk haplotypes observed in GWAS cases).
(DOCX)
Table S4 Exonic variants for deafness on CFA6. A list of the 26
exonic variants for CFA6 plus annotations is given in Table S4.
Gene annotations and predicted amino acid (AA) changes (single
letter AA abbreviations flanking AA position) are given with
reference to the gene in the human unless the gene is not present
in human, in which case it is given for the species noted (Mus –
mouse, Sac – yeast, Bos – cow, Rat – rat). Non-synonymous SNPs
(nsSNP) are marked in bold. In addition to the called genotypes for
each sample, the sequence coverage for that SNP is also provided.
Finally, the phastCons4Way score provides a measure of
conservation for each position, where values closer to 1 indicate
the base is more highly conserved across species. Conservation is
based on alignment with human (hg17), mouse (mm6), and rat
(rn3). CFA: canine chromosome; Position: base position; Ref:
reference allele from genome; Alt: alternate allele observed in
sample[s]; genotype: 0 = reference allele, 1 = alternate allele;
phastCons score: phastCons4Way score from UCSC genome
browser. Of the 26 putative exonic variants, only 8 were annotated
to be non-synonymous changes. Four nsSNPs were found in
Abca14, which was the gene with the most nsSNPs. Abca14 is an
ATP binding cassette transporter gene that has only been
annotated in the genomes of rodents [33]. Conservation scores
for all four of these nsSNPs were low, suggesting that this gene
may not be active and thus tolerant of non-synonymous changes
more readily. There was an additional gene containing an nsSNPs,
that is not readily linked to hearing function or expression
(EEF2K).
(DOCX)
Table S5 List of primers used in dye-terminator sequencing.
Follow-up sequencing was performed in additional samples for
three variants. The PCR conditions used are described in Materials
and Methods.
(DOCX)
Table S6 List of predicted genes targeted for target capture
sequencing and probe coverage by gene. Position of targeted
region in canFam2 and number of targets per gene are listed for all
target capture regions. An ‘‘n/a’’ is used when a target gene is
within another predicted gene that has already been targeted.
(DOCX)
Table S7 Gene coverage information by gene for each target
capture sample. Percent bases covered and average coverage
depth is provided for each sample that was sequenced using next-
generation technology. Coverage is listed by target gene.
(DOCX)
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